HYPHEN BioMed is a leading French manufacturer of hemostasis reagents, specializing in chromogenic, clotting, and immunological assays for hospital coagulation laboratories and research institutions worldwide.
Aniara Diagnostica is the exclusive distributor of HYPHEN BioMed products across the United States, Canada, and the Nordic and Baltic regions — including Sweden, Norway, Denmark, Finland, Iceland, Lithuania, Latvia, and Estonia.
The HYPHEN BioMed portfolio covers the complete hemostasis testing menu — from routine global coagulation screening with CEPHEN™ APTT, PT-Phen™, and FIBRIPHEN™ reagents, to specialized DOAC monitoring with BIOPHEN™ and HEMOCLOT™ assays, thrombophilia workups, platelet function testing, HIT antibody detection, hemophilia management, fibrinolysis assessment, and pharmacopoeial industrial QC.
Many products carry both FDA 510(k) clearance and CE-IVD marking, making them suitable for clinical laboratory use in the US, Canada, and Europe.